Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human mon...
Leadership
Nevan Charles Elam J.D.Founder
Founder, CEO, Principal Financial Officer & Acting Chairman of the Board
Daron G. Evans M.B.A., M.S.
Chief Financial & Business Officer
Brian Kenneth Roberts M.D.
Chief Medical Officer
Michael R. Deperro
Senior VP & Head of Operations
Davelyn Eaves Hood M.B.A., M.D.
Director and Head of Scientific & Patient Affairs
Melissa Quinn
Senior Director of People and Culture
Michael Covarrubias
Senior VP & Head of Program & Portfolio Management
Chris Milks
VP & Head of Finance
Raj Agrawal M.D.
VP & Head of Ophthalmological Clinical Development
